This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lefebvre, H. Articles by Kuhn, J.-M. Search for Related Content PubMed PubMed Citation Articles by Lefebvre, H. Articles by Kuhn, J.-M.

Production and Metabolism of Serotonin (5-HT) by the Human Adrenal Cortex: Paracrine Stimulation of Aldosterone Secretion by 5-HT

European Institute for Peptide Research (IFRMP 23), Department of Endocrinology, INSERM U413, University Hospital of Rouen, (H.L., J.M.K.) 76031 Rouen, France; Laboratory of Cellular and Molecular Neuroendocrinology, INSERM U413, Unite Associée Centre National de la Recherche Scientifique, University of Rouen, (H.L., V.C., C.D., H.V., J.M.K.) 76821 Mont-Saint-Aignan, France; and Department of Pharmacology, INSERM E 9920, University Hospital of Rouen, (P.C., C.T.) 76031 Rouen, France

Address all correspondence and requests for reprints to: Dr. Hervé Lefebvre, IFRMP 23, Department of Endocrinology, INSERM U413, Hospital of Boisguillaume, University Hospital of Rouen, 76031 Rouen cedex, France. E-mail: herve.lefebvre{at}chu-rouen.fr

Abstract

In the human adrenal cortex, serotonin (5-HT) is contained in mast-like cells, and we have shown that 5-HT stimulates aldosterone secretion, suggesting that 5-HT may control glomerulosa cells through a paracrine mechanism. Concurrently, the presence of 5-hydroxyindolacetic acid in human adrenocortical extracts indicates that 5-HT may be metabolized after local release by mast cells. The aim of the present study was to investigate in vitro the production and metabolism of 5-HT by the human adrenal cortex. Perifused adrenal slices released spontaneously detectable amounts of 5-HT (0.74 ± 0.38 fmol/mg wet tissue·min). The mast cell-depleting drug compound 48/80 induced a burst of 5-HT secretion followed by a gradual increase in aldosterone production. Administration of the specific 5-HT₄ receptor antagonist GR 113808 (10^-6 M) did not affect compound 48/80-induced 5-HT release but abolished the stimulatory effect of compound 48/80 on aldosterone secretion, indicating that 5-HT released locally is responsible for a paracrine control of steroidogenesis.

Incubation of cells from the human adrenal cortex with 5-HT (10^-5 M) provoked the formation of the 5-HT metabolite 5-hydroxytryptophol. The type A monoamine oxidase (MAO) inhibitor clorgyline (10^-6 M) suppressed the metabolism of 5-HT into 5-hydroxytryptophol. Immunocytochemical staining of cultured cells revealed the presence of a subpopulation of MAO-A-positive cells. Double labeling with an antiserum against chromogranin A showed that MAO-A was actually contained in chromaffin cells. Similarly, immunohistochemical staining of adrenal slices showed that MAO-A was expressed in chromaffin cells located both in the medulla and in intracortical rays.

In conclusion, the present study shows that, in the human adrenal cortex, 5-HT, released by mast-cells, may stimulate aldosterone secretion in a paracrine manner. Our data also indicate that 5-HT is metabolized by MAO-A located in intracortical chromaffin cells.

This article has been cited by other articles:

				E Louiset, K Isvi, J M Gasc, C Duparc, B Cauliez, A Laquerriere, J M Kuhn, and H Lefebvre Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol Endocr. Relat. Cancer, December 1, 2008; 15(4): 1025 - 1034. [Abstract] [Full Text] [PDF]

				D. Cartier, S. Jegou, F. Parmentier, I. Lihrmann, E. Louiset, J.-M. Kuhn, C. Bastard, P.-F. Plouin, M. Godin, H. Vaudry, et al. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas Eur. J. Endocrinol., December 1, 2005; 153(6): 939 - 947. [Abstract] [Full Text] [PDF]

				V. Contesse, Y. Reznik, E. Louiset, C. Duparc, D. Cartier, F. Sicard, A. Laquerriere, F. Parmentier, J.-M. Kuhn, H. Vaudry, et al. Abnormal Sensitivity of Cortisol-Producing Adrenocortical Adenomas to Serotonin: In Vivo and in Vitro Studies J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2843 - 2850. [Abstract] [Full Text] [PDF]

				J. Bertherat, V. Contesse, E. Louiset, G. Barrande, C. Duparc, L. Groussin, P. Emy, X. Bertagna, J.-M. Kuhn, H. Vaudry, et al. In Vivo and in Vitro Screening for Illegitimate Receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing's Syndrome: Identification of Two Cases of Gonadotropin/Gastric Inhibitory Polypeptide-Dependent Hypercortisolism J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1302 - 1310. [Abstract] [Full Text] [PDF]

				A. Slominski, J. Wortsman, and D. J. Tobin The cutaneous serotoninergic/melatoninergic system: securing a place under the sun FASEB J, February 1, 2005; 19(2): 176 - 194. [Abstract] [Full Text] [PDF]

				M. Mannelli, P. Ferruzzi, P. Luciani, C. Crescioli, L. Buci, G. Corona, M. Serio, and A. Peri Cushing's Syndrome in a Patient with Bilateral Macronodular Adrenal Hyperplasia Responding to Cisapride: An in Vivo and in Vitro Study J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4616 - 4622. [Abstract] [Full Text] [PDF]

				R. A. Feelders, S. W. J. Lamberts, L. J. Hofland, P. M. van Koetsveld, M. Verhoef-Post, A. P. N. Themmen, F. H. de Jong, H. J. Bonjer, A. J. Clark, A.-J. van der Lely, et al. Luteinizing Hormone (LH)-Responsive Cushing's Syndrome: The Demonstration of LH Receptor Messenger Ribonucleic Acid in Hyperplastic Adrenal Cells, which Respond to Chorionic Gonadotropin and Serotonin Agonists in Vitro J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 230 - 237. [Abstract] [Full Text] [PDF]

				H. Lefebvre, D. Cartier, C. Duparc, I. Lihrmann, V. Contesse, C. Delarue, M. Godin, R. Fischmeister, H. Vaudry, and J.-M. Kuhn Characterization of Serotonin4 Receptors in Adrenocortical Aldosterone-Producing Adenomas: In Vivo and in Vitro Studies J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1211 - 1216. [Abstract] [Full Text] [PDF]